Racial disparities in incidence and outcome in multiple myeloma: a population-based study.
Multiple myeloma (MM) is the most common hematologic malignancy in blacks. Some prior studies suggest inferior survival in blacks; others suggest similar survival. Using the original 9 Surveillance, Epidemiology, and End Results registries, we conducted a large-scale population-based study including 5798 black and 28 939 white MM patients diagnosed 1973-2005, followed through 2006. Age-adjusted incidence rates, disease-specific survival, and relative survival rates were calculated by race, age, and time period of diagnosis. Mean age at diagnosis was 65.8 and 69.8 years for blacks and whites, respectively (P < .001). Incidence among blacks was m twice that among whites; this disparity was greater among patients < 50 years (P = .002). Over the entire study period, disease-specific and relative survival rates were higher in blacks than whites (P < .001). For whites, 5-year relative survival rates increased significantly 1973-1993 to 1994-1998 (26.3% to 30.8%; P < .001) and 1994-1998 to 1999-2005 (30.8% to 35.0%; P = .004). Survival improvements among blacks were smaller and nonsignificant (1973-1993 to 1999-2005: 31.0% to 34.1%; P = .07). We found (1) a younger age of onset among blacks; (2) better survival in blacks 1973-2005; and (3) significant survival improvement among whites over time, with smaller, nonsignificant change seen among blacks, possibly due to unequal access to and/or disparate responsiveness to novel therapies.
Waxman
Adam J
AJ
National Cancer Institute, Bethesda, MD, USA.
Mink
Pamela J
PJ
Devesa
Susan S
SS
Anderson
William F
WF
Weiss
Brendan M
BM
Kristinsson
Sigurdur Y
SY
McGlynn
Katherine A
KA
Landgren
Ola
O
D000367:Age Factors; D000368:Aged; D044383:Black People / Q000706:statistics & numerical data*; D005260:Female; D054625:Healthcare Disparities / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000208:ethnology* / Q000628:therapy; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D044465:White People / Q000706:statistics & numerical data*
Br J Haematol. 2003 Jun;121(5):749-57
12780789
Blood. 2006 Sep 15;108(6):2020-8
16728703
J Clin Oncol. 1996 Mar;14(3):974-7
8622048
N Engl J Med. 2003 Dec 25;349(26):2495-502
14695409
Lancet. 1998 Mar 28;351(9107):934-9
9734939
N Engl J Med. 2009 Jun 18;360(25):2645-54
19535803
Am J Med. 1978 May;64(5):814-26
645746
Am J Epidemiol. 1995 Feb 15;141(4):300-4
7840107
Cancer Causes Control. 2006 Sep;17(7):931-8
16841260
J Clin Oncol. 2002 Nov 1;20(21):4319-23
12409330
N Engl J Med. 1980 Jun 12;302(24):1347-9
7374679
Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1117-21
10613347
N Engl J Med. 2006 Mar 30;354(13):1362-9
16571879
N Engl J Med. 1996 Jul 11;335(2):91-7
8649495
Cancer. 1989 Mar 1;63(5):982-7
2914303
Blood. 2006 Feb 1;107(3):904-6
16210333
Blood. 2008 Mar 1;111(5):2516-20
17975015
Blood. 2009 May 28;113(22):5412-7
19179464
N Engl J Med. 2003 Jun 26;348(26):2609-17
12826635
N Engl J Med. 2007 Nov 22;357(21):2123-32
18032762
Blood. 1994 Aug 1;84(3):950-6
7913845
Haematologica. 2006 Oct;91(10):1410-3
16963396
Am J Hematol. 2008 May;83(5):355-8
18186525
JAMA. 1969 Jun 2;208(9):1680-5
5818682
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
19474385
J Natl Med Assoc. 2006 Nov;98(11):1860-1
17128699
Blood. 2008 Mar 1;111(5):2521-6
17901246
N Engl J Med. 2008 Aug 28;359(9):906-17
18753647
Mayo Clin Proc. 2007 Dec;82(12):1468-73
18053453
Blood. 2009 May 28;113(22):5418-22
19234139
N Engl J Med. 2004 Oct 28;351(18):1860-73
15509819
J Clin Oncol. 2001 Jan 1;19(1):18-27
11134191
Biometrics. 1983 Dec;39(4):941-8
6671129
Am J Clin Oncol. 2007 Oct;30(5):540-8
17921717
Lancet Oncol. 2010 Jan;11(1):29-37
19853510
Blood. 2009 Jul 23;114(4):791-5
19182202
J Clin Oncol. 2007 May 20;25(15):1993-9
17420512
J Natl Cancer Inst. 2009 Dec 2;101(23):1610
19910557
N Engl J Med. 1999 Nov 18;341(21):1565-71
10564685
Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402
19922808
Cancer. 1984 Dec 15;54(12):3085-94
6498786
J Clin Oncol. 2010 Feb 10;28(5):830-4
20038719
JAMA. 2002 Apr 24;287(16):2106-13
11966385
Int J Cancer. 2009 Nov 1;125(9):2147-50
19582882
Cancer Metastasis Rev. 2003 Mar;22(1):87-93
12716040